These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17964220)

  • 1. Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy.
    Gardulf A; Borte M; Ochs HD; Nicolay U;
    Clin Immunol; 2008 Jan; 126(1):81-8. PubMed ID: 17964220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.
    Gardulf A; Nicolay U; Math D; Asensio O; Bernatowska E; Böck A; Costa-Carvalho BT; Granert C; Haag S; Hernández D; Kiessling P; Kus J; Matamoros N; Niehues T; Schmidt S; Schulze I; Borte M
    J Allergy Clin Immunol; 2004 Oct; 114(4):936-42. PubMed ID: 15480339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies.
    Gardulf A; Nicolay U
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):434-42. PubMed ID: 17088648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.
    Stein MR; Koterba A; Rodden L; Berger M
    Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G.
    Berger M; Murphy E; Riley P; Bergman GE;
    South Med J; 2010 Sep; 103(9):856-63. PubMed ID: 20689467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcutaneous gammaglobulin in common variable immunodeficiency. First experience in Spain].
    Maroto Hernando M; Soler Palacín P; Martin Nalda N; Oliveras Arenas M; Español Boren T; Figueras Nadal C
    An Pediatr (Barc); 2009 Feb; 70(2):111-9. PubMed ID: 19217565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home self-administration of intravenous immunoglobulin therapy in children.
    Kobayashi RH; Kobayashi AD; Lee N; Fischer S; Ochs HD
    Pediatrics; 1990 May; 85(5):705-9. PubMed ID: 2109852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency.
    Fasth A; Nyström J
    Acta Paediatr; 2007 Oct; 96(10):1474-8. PubMed ID: 17850391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency.
    Hoffmann F; Grimbacher B; Thiel J; Peter HH; Belohradsky BH;
    Eur J Med Res; 2010 Jun; 15(6):238-45. PubMed ID: 20696632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".
    Bienvenu B; Cozon G; Hoarau C; Pasquet M; Cherin P; Clerson P; Hachulla E; Crave JC; Delain JC; Jaussaud R
    Orphanet J Rare Dis; 2016 Jun; 11(1):83. PubMed ID: 27334100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route.
    Gardulf A
    BioDrugs; 2007; 21(2):105-16. PubMed ID: 17402794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profile, Dosing, and Quality-of-Life Outcomes in Primary Immune Deficiency Patients Treated at Home with Immunoglobulin G: Data from the IDEaL Patient Registry.
    Kearns S; Kristofek L; Bolgar W; Seidu L; Kile S
    J Manag Care Spec Pharm; 2017 Apr; 23(4):400-406. PubMed ID: 28345437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of patients with primary antibody deficiencies in Germany].
    Borte M; Oertelt C; Högy B
    Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous immunoglobulin replacement therapy with Hizentra, the first 20% SCIG preparation: a practical approach.
    Jolles S; Sleasman JW
    Adv Ther; 2011 Jul; 28(7):521-33. PubMed ID: 21681653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis.
    Shapiro RS
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):51-5. PubMed ID: 23806460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
    Shapiro RS
    Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home.
    Nicolay U; Kiessling P; Berger M; Gupta S; Yel L; Roifman CM; Gardulf A; Eichmann F; Haag S; Massion C; Ochs HD
    J Clin Immunol; 2006 Jan; 26(1):65-72. PubMed ID: 16418804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases.
    Haddad É; Barnes D; Kafal A
    Transfus Apher Sci; 2012 Jun; 46(3):315-21. PubMed ID: 22503304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies.
    Berger M; Rojavin M; Kiessling P; Zenker O
    Clin Immunol; 2011 May; 139(2):133-41. PubMed ID: 21353644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of hospital-based intravenous immunoglobulin and home-based self-administrated subcutaneous immunoglobulin therapy in young children with primary immunodeficiency diseases on their parents' / caregivers' satisfaction.
    Lechanska-Helman J; Sobocinska A; Jerzynska J; Stelmach I
    Pediatr Int; 2020 Mar; 62(3):316-318. PubMed ID: 31880367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.